Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
James J. Hsieh(Memorial Sloan Kettering Cancer Center), David Chen(Novartis (United States)), Patricia I. Wang(Memorial Sloan Kettering Cancer Center), Mahtab Marker(Novartis (United States)), Almedina Redzematovic(Memorial Sloan Kettering Cancer Center), Ying‐Bei Chen(Memorial Sloan Kettering Cancer Center), S. Duygu Selçuklu(Memorial Sloan Kettering Cancer Center), Nils Weinhold(Memorial Sloan Kettering Cancer Center), Nancy Bouvier(Memorial Sloan Kettering Cancer Center), Kety Huberman(Memorial Sloan Kettering Cancer Center), Umesh Bhanot(Memorial Sloan Kettering Cancer Center), Michael Chevinsky(Barnes-Jewish Hospital), Parul Patel(Novartis (United States)), Patrizia Pinciroli(Memorial Sloan Kettering Cancer Center), Helen Won(Memorial Sloan Kettering Cancer Center), Daoqi You(Memorial Sloan Kettering Cancer Center), Agnès Viale(Memorial Sloan Kettering Cancer Center), William Lee(Memorial Sloan Kettering Cancer Center), A. Ari Hakimi(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Nicholas D. Socci(Memorial Sloan Kettering Cancer Center), Emily H. Cheng(Memorial Sloan Kettering Cancer Center), Jennifer J. Knox(Princess Margaret Cancer Centre), Martin H. Voss(Memorial Sloan Kettering Cancer Center), Maurizio Voi(Novartis (United States)), Robert J. Motzer(Memorial Sloan Kettering Cancer Center)
Cited by 202Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis